Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 08 03 2019
accepted: 02 07 2019
pubmed: 14 9 2019
medline: 25 8 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Skull base osteosarcomas are aggressive neoplasms characterized by bony invasion and extracompartmental/extra-osseous soft tissue extension that pose obstacles to achieving complete resection. Management is further complicated by the paucity of data regarding the efficacy of surgery within the treatment paradigm. To identify the impact of margin status on local progression free survival (PFS) and disease specific survival (DSS). A retrospective review was performed of 36 patients with osteosarcoma who underwent gross total resection with negative margins (R0), or positive margins (R1). Patient demographics, prior treatments, relapse patterns, and survival were collected. Univariate analysis was performed to determine the impact of margin status on the PFS (primary outcome) and DSS (secondary outcome). R0 resection was achieved in 67%, 25% patients had local recurrence, and 19.4% patients had distant metastasis. In assessing the entire cohort, R0 resections had improved DSS (P = .002) and PFS (P = .04). In chemotherapy-naïve patients, R0 resections also had improved impact on PFS (P = .04) and DSS (P = .027). For radiation-naïve patients, improvements in PFS (P = .026) and DSS (P = .031) were also noted. Skull base osteosarcomas present management challenges in which both local and systemic disease progression is the cause of mortality. Achieving R0 resections significantly improves PFS and DSS in treatment-naïve patients within multimodality treatment paradigms. Salvage surgery may benefit in patients after failing previous radiation and chemotherapy treatments. Further work is needed to determine optimal treatment strategies. These data represent the largest series reported to date.

Sections du résumé

BACKGROUND
Skull base osteosarcomas are aggressive neoplasms characterized by bony invasion and extracompartmental/extra-osseous soft tissue extension that pose obstacles to achieving complete resection. Management is further complicated by the paucity of data regarding the efficacy of surgery within the treatment paradigm.
OBJECTIVE
To identify the impact of margin status on local progression free survival (PFS) and disease specific survival (DSS).
METHODS
A retrospective review was performed of 36 patients with osteosarcoma who underwent gross total resection with negative margins (R0), or positive margins (R1). Patient demographics, prior treatments, relapse patterns, and survival were collected. Univariate analysis was performed to determine the impact of margin status on the PFS (primary outcome) and DSS (secondary outcome).
RESULTS
R0 resection was achieved in 67%, 25% patients had local recurrence, and 19.4% patients had distant metastasis. In assessing the entire cohort, R0 resections had improved DSS (P = .002) and PFS (P = .04). In chemotherapy-naïve patients, R0 resections also had improved impact on PFS (P = .04) and DSS (P = .027). For radiation-naïve patients, improvements in PFS (P = .026) and DSS (P = .031) were also noted.
CONCLUSION
Skull base osteosarcomas present management challenges in which both local and systemic disease progression is the cause of mortality. Achieving R0 resections significantly improves PFS and DSS in treatment-naïve patients within multimodality treatment paradigms. Salvage surgery may benefit in patients after failing previous radiation and chemotherapy treatments. Further work is needed to determine optimal treatment strategies. These data represent the largest series reported to date.

Identifiants

pubmed: 31515560
pii: 5568465
doi: 10.1093/neuros/nyz360
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E23-E32

Informations de copyright

Copyright © 2019 by the Congress of Neurological Surgeons.

Auteurs

Shaan M Raza (SM)

Department of Neurosurgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Ahmed Habib (A)

Department of Neurosurgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Wei-Lien Wang (WL)

Department of Pathology, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Paul W Gildey (PW)

Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Anthony P Conley (AP)

Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Marc-Elie Nader (ME)

Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Ehab Y Hanna (EY)

Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Shirley Y Su (SY)

Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Franco DeMonte (F)

Department of Neurosurgery, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH